Increased US activity led to management change in Bioporto
Increased activity on the US market is the reason for a change of guards at the helm of the Danish diagnostics group Bioporto’s operations.
BY ANTON GRÆSDAL MAAJEN
Denmark-based diagnostics group Bioporto said in a brief announcement this week that it has hired Jan Kuhlmann Andersen as its new Chief Operations instead of Michael Pålsson. Bioporto’s CEO, Peter Mørch Eriksen, now tells MedWatch why a change was needed.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Bioporto makes management change
For abonnenter
Bioporto: It’s a great start to 2016
For abonnenter
